A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.
about
A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
A clinically feasible multiple ...... creatic ductal adenocarcinoma.
@en
A clinically feasible multiple ...... creatic ductal adenocarcinoma.
@nl
type
label
A clinically feasible multiple ...... creatic ductal adenocarcinoma.
@en
A clinically feasible multiple ...... creatic ductal adenocarcinoma.
@nl
prefLabel
A clinically feasible multiple ...... creatic ductal adenocarcinoma.
@en
A clinically feasible multiple ...... creatic ductal adenocarcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
A clinically feasible multiple ...... creatic ductal adenocarcinoma.
@en
P2093
Andrea Wang-Gillam
Daniel K Mullady
Dayna S Early
Dengfeng Cao
Emma Langley
Faris M Murad
Gary Meyer
Kian-Huat Lim
Phillip Kim
P2860
P304
24250-24261
P356
10.18632/ONCOTARGET.15653
P407
P577
2017-04-01T00:00:00Z